National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

cevimeline hydrochloride
A cholinergic analogue with glandular secretion stimulatory activity. Cevimeline binds to and activates muscarinic receptors, thereby increasing the secretions in exocrine salivary and sweat glands. This cholinergic agonist also increases the tone of smooth muscle in the gastrointestinal and urinary tracts. Cevimeline is being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:cevimeline
US brand name:Evoxac
Code name:AF-102B



Previous:cesium Cs 137, Cetacort, Cetane, cetuximab, Cevalin
Next:chamomile, Chantix, checkpoint kinase inhibitor AZD7762, Chemophase, chimeric anti-phosphotidylserine monoclonal antibody

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov